- Home
- NVCT vs TSVT Comparison
NVCT vs TSVT Comparison
Compare NVCT & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- TSVT
- Stock Information
- Founded
- NVCT 2020
- TSVT 2021
- Country
- NVCT United States
- TSVT United States
- Employees
- NVCT N/A
- TSVT N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- NVCT Health Care
- TSVT Health Care
- Exchange
- NVCT Nasdaq
- TSVT Nasdaq
- Market Cap
- NVCT 249.1M
- TSVT 258.9M
- IPO Year
- NVCT 2022
- TSVT N/A
- Fundamental
- Price
- NVCT $8.99
- TSVT $4.99
- Analyst Decision
- NVCT Strong Buy
- TSVT Buy
- Analyst Count
- NVCT 3
- TSVT 4
- Target Price
- NVCT $17.00
- TSVT $6.50
- AVG Volume (30 Days)
- NVCT 157.3K
- TSVT 726.2K
- Earning Date
- NVCT 05-06-2025
- TSVT 05-07-2025
- Dividend Yield
- NVCT N/A
- TSVT N/A
- EPS Growth
- NVCT N/A
- TSVT N/A
- EPS
- NVCT N/A
- TSVT N/A
- Revenue
- NVCT N/A
- TSVT $48,365,000.00
- Revenue This Year
- NVCT N/A
- TSVT $84.48
- Revenue Next Year
- NVCT N/A
- TSVT $9.69
- P/E Ratio
- NVCT N/A
- TSVT N/A
- Revenue Growth
- NVCT N/A
- TSVT N/A
- 52 Week Low
- NVCT $4.44
- TSVT $2.29
- 52 Week High
- NVCT $11.80
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- NVCT 47.46
- TSVT 71.10
- Support Level
- NVCT $8.01
- TSVT $4.97
- Resistance Level
- NVCT $9.62
- TSVT $4.99
- Average True Range (ATR)
- NVCT 1.04
- TSVT 0.01
- MACD
- NVCT -0.16
- TSVT -0.04
- Stochastic Oscillator
- NVCT 27.96
- TSVT 50.00
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.